Jennifer Jarrett Arcus Biosciences, Inc. (RCUS) insider trading activity

Jennifer Jarrett is Chief Operating Officer of Arcus Biosciences, Inc.. Currently has a direct ownership of 193,024 shares of RCUS, which is worth approximately $3.87 Million. The most recent transaction as insider was on Mar 16, 2023, when has been sold 8,729 shares (Common Stock) at a price of $16.81 per share, resulting in proceeds of $146,734. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K

9.9% 3M change

18.15% 12M change

Total Value Held $3.87 Million

Jennifer Jarrett Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 16 2023	SELL Open market or private sale	$146,734 $16.81 p/Share	8,729 Reduced 2.1%	406,217 Common Stock
Jan 27 2023	SELL Open market or private sale	$37,632 $23.52 p/Share	1,600 Reduced 0.38%	414,946 Common Stock
Jan 26 2023	SELL Open market or private sale	$7,068 $23.56 p/Share	300 Reduced 0.07%	416,546 Common Stock
Jan 23 2023	BUY Grant, award, or other acquisition	-	45,800 Added 9.9%	416,846 Common Stock
Dec 16 2022	SELL Open market or private sale	$510,117 $30.95 p/Share	16,482 Reduced 10.04%	147,609 Common Stock
Sep 16 2022	SELL Open market or private sale	$333,152 $26.28 p/Share	12,677 Reduced 8.83%	130,942 Common Stock
Jun 17 2022	SELL Open market or private sale	$145,508 $22.0 p/Share	6,614 Reduced 5.28%	118,619 Common Stock

Jun 16 2022	SELL Open market or private sale	$125,998 $20.72 p/Share	6,081 Reduced 4.63%	125,233 Common Stock
Mar 16 2022	SELL Open market or private sale	$304,090 $31.62 p/Share	9,617 Reduced 8.32%	105,978 Common Stock
Mar 08 2022	BUY Grant, award, or other acquisition	-	31,250 Added 20.41%	121,845 Common Stock
Dec 20 2021	SELL Open market or private sale	$1,448,595 $41.6 p/Share	34,822 Reduced 27.76%	90,595 Common Stock
Dec 17 2021	SELL Open market or private sale	$285,503 $40.11 p/Share	7,118 Reduced 5.37%	125,417 Common Stock
Dec 16 2021	SELL Open market or private sale	$222,567 $40.03 p/Share	5,560 Reduced 4.03%	132,535 Common Stock
Sep 21 2021	SELL Open market or private sale	$602,791 $35.74 p/Share	16,866 Reduced 13.0%	112,843 Common Stock
Sep 20 2021	SELL Open market or private sale	$1,084,444 $35.4 p/Share	30,634 Reduced 19.11%	129,709 Common Stock
Jun 17 2021	SELL Open market or private sale	$115,156 $23.68 p/Share	4,863 Reduced 3.47%	135,343 Common Stock
Jun 16 2021	SELL Open market or private sale	$97,018 $24.45 p/Share	3,968 Reduced 2.75%	140,206 Common Stock
Jun 04 2021	SELL Open market or private sale	$26,006 $24.91 p/Share	1,044 Reduced 0.87%	119,174 Common Stock
Mar 16 2021	SELL Open market or private sale	$303,395 $35.03 p/Share	8,661 Reduced 6.89%	116,973 Common Stock
Jan 19 2021	BUY Grant, award, or other acquisition	-	400,000 Added 44.41%	500,634 Common Stock

Also insider at

SNDX

Syndax Pharmaceuticals Inc Healthcare

ARNA

ARENA PHARMACEUTICALS INC Healthcare

Director

SRZN

Surrozen, Inc. Healthcare

RDUS

Radius Health, Inc. Healthcare

Director

JATT-WT

JATT Acquisition Corp

SGMT

Sagimet Biosciences Inc.

Director